MYTELASE 10 mg, tablet 50 tablets
Active ingredients: Ambenonium chloride
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Tablet50 tabletsorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- MYTELASE 10 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun de 50 comprimé(s)
- Marketing authorisation holder
- NEURAXPHARM FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jan 1958
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60374821CIP73069848CIP133400930698488Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORURE D'AMBÉNONIUMcomprimé | 10 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.